Bioprosthetics market seen rising to $9.77 billion by 2030

The Business Research Company says the global bioprosthetics market will grow from $6.27 billion in 2025 to $6.86 billion in 2026, then reach $9.77 billion by 2030. Demand is being driven by cardiovascular disease, more reconstructive and orthopedic surgeries, and new AI-enabled and personalized implant technologies.

Why it matters: - Bioprosthetics are used to replace or support damaged tissue with biologically compatible implants. - Rising demand for these devices reflects more cardiovascular disease, more surgeries, and broader adoption of advanced implant technology. - The market outlook points to continued growth in a medical category tied directly to heart, orthopedic and reconstructive care.

What happened: - The Business Research Company released its "Bioprosthetics Market Report 2026 – Market Size, Trends, And Global Forecast 2026-2035." - The report estimates the bioprosthetics market will grow from $6.27 billion in 2025 to $6.86 billion in 2026. - The report projects the market will reach $9.77 billion by 2030. - North America held the largest market share in 2025. - Asia-Pacific is expected to be the fastest-growing region over the forecast period.

The details: - The report links historical growth to constraints related to biocompatible materials, high incidence of tissue injuries, drawbacks of traditional prosthetic devices, more surgical interventions and lack of smart prosthetic integration. - Forecast growth is tied to personalized implants, tissue-engineered constructs, AI-powered prosthetic innovations, smart prosthetics and rising orthopedic and reconstructive surgery volumes. - Trends highlighted in the report include AI-enhanced prosthetic design, deeper use of biocompatible materials, customized implant production, sensor-equipped smart prosthetics and tissue engineering. - Bioprosthetics are defined in the report as implants or devices made from biological substances, sometimes combined with synthetic materials. - The materials are engineered to mimic natural tissue structure and function, support immune compatibility, reduce rejection risk and provide durability. - Cardiovascular disease is a major market driver and includes coronary artery disease, heart failure, arrhythmias, congenital heart defects and stroke. - Poor dietary habits with high saturated fat, salt and sugar intake are cited as contributors to obesity, hypertension and elevated cholesterol. - The American Heart Association reported in January 2024 that cardiovascular-related deaths in the US reached 931,578 in 2023, up from 928,741 in 2022. - The report says the market analysis covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The 2026 report package includes market attractiveness scoring, total addressable market analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, and updated graphics and tables. - The report offers a free sample at Download a free sample. - The full report is available at View the full report.

Between the lines: - The forecast suggests bioprosthetics are moving from a niche implant category toward a more technology-driven market. - AI, smart sensors and customized production point to a shift from standard prosthetics toward more patient-specific devices. - The regional split suggests mature demand in North America and faster adoption potential in Asia-Pacific.

What's next: - The market is expected to keep expanding through 2030 at a 9.2% compound annual growth rate. - Continued growth will likely depend on progress in personalized implants, tissue engineering and smarter prosthetic systems. - More orthopedic and reconstructive procedures should add to demand if current surgery trends continue. - The Business Research Company says the report is part of its updated 2026 market research package.